Tivicay
Payments companies reported to CMS as associated with Tivicay. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tivicay, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tivicay
These are the largest totals companies reported as associated with Tivicay. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Katharine Bar | Philadelphia, PA | Infectious Disease | $118.58 |
| Timothy Wilkin | San Diego, CA | Infectious Disease | $118.57 |
| Shobha Swaminathan | Newark, NJ | Infectious Disease | $118.57 |
| Sonya Heath | Birmingham, AL | Infectious Disease | $118.57 |
| Geeta Gupta | Orange, CA | Infectious Disease | $118.57 |
| Aimee Wilkin | Winston Salem, NC | Infectious Disease | $118.57 |
| Bernard Camins | Saint Louis, MO | Infectious Disease | $114.45 |
| Olga Wildfeuer | Brooklyn, NY | Internal Medicine | $10.29 |
Prescribed Tivicay?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.